FDA recall D-169-2013

Hospira, Inc. · Class II · drug

Product

Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04

Reason for recall

Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-01-10
Report date
2013-03-06
Termination date
2014-10-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Rocky Mount, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-169-2013